54:16

Current Treatment Options and Things to Consider for Myelofibrosis Patients with Anand Patel, MD

01:00:49

Veneteclax: Everything You Need To Know

38:49

Estate and Legacy Planning for Blood Cancer Patients: Protect Your Future and Leave a Lasting Impact

51:26

To Treat or Not To Treat? A Discussion about Early Intervention for Myelofibrosis with Dr. Yacoub.

42:10

CAR-T Therapy and Stem cell transplant in Lymphoma patients: Current treatment landscape

59:40

Things to Think About When Choosing a Chronic Lymphocytic Leukemia treatment with Joanna Rhodes, MD

59:41

Caring for the Caregiver: Effective Stress Management Strategies

54:21

How does diet impact Myeloproliferative Neoplasms? with Angela Fleischman, MD

01:04:49

Upcoming Changes to Medicare for 2025

01:25:51

Innovation in Blood Cancer

58:05

Community and Academic Centers Working Together For Best Patient Outcomes

04:13

"Taking Back Control Through Education": Cecily's Cancer Story

57:50

Combination Therapies in Myelofibrosis

36:47

All About Tumor Lysis Syndrome in DLBCL

48:36

What are the Current CLL Clinical Trials? With Ryan Jacobs, MD

03:49

"My Myeloma Doesn't Define Me": Susana's Cancer Story

58:31

What If I Don't Qualify for Transplant? for AML Patients

40:46

Tips to Managing Fatigue Associated with CLL with Allyson Armstrong, DPT

04:00

"I Am Determined To Live": Andre'a's Cancer Story

00:50

Real Cancer Stories: Janet Schurmann

58:04

Clinical Trials 101

54:13

Treatment options for DLBCL

35:28

From Trial to Triumph: Robyn's Pioneering CAR-T Therapy Journey

54:33

Hot Topics in Diffuse Large B-Cell Lymphoma

44:58

HealthTree Coach & A Second Opinion Saved My Life - Taye and Steve's Story

57:10

How Often Do I Need CLL Tests? with Nitin Jain, M.D

30:57

Track Your MDS Labs: Know where to start!

10:40

Lessons From A Cancer Survivor - Alan's Story

38:51

Monoclonal Antibodies and their role in DLBCL Treatment

56:47

Bone Marrow Transplant in MDS and AML

02:39

Efficacy of Navitoclax and Ruxolitinib | Naveen Pemmaraju, MD | EHA 2024

02:31

Golcadomide ± Rituximab in R/R Follicular Lymphoma: Phase 1/2 Study | Julio Chavez, MD | EHA 2024

02:41

CAR-T is Feasible in B-Cell Lymphoma Patients Over 80 Years Old | Julio Chavez, MD | EHA 2024

04:37

RELAZA2 Results: Azacitidine Use in MDS & AML | Anne Sophie Kubasch, MD | EHA 2024

04:05

CELMOD in Lymphoma Treatment: Phase 1/2 Study Insights | Marc Hoffman, MD | EHA 2024

06:34

OUTCOMES OF PATIENTS WITH AML WITH MYELODYSPLASIA-RELATED CHANGES | Maria Voso, MD | EHA 2024

06:06

Discussing the Unmet Clinical Needs in 2 Special CLL Patient Groups | Silvia Deaglio, MD | EHA 2024

49:18

Patient Navigation: A Guide for Cancer Patients

01:05:14

How Are CLL Medicines' Side Effects Managed?

47:32

Palliative Care for Blood Cancer Patients and Caregivers

33:45

MDS or MPN?

44:32

Hospice: Myths vs Facts

44:46

Why I am Grateful for my Follicular Lymphoma Diagnosis

39:12

Understanding and Tracking AML Labs

54:47

Medicaid and Common Estate Planning Mistakes

59:54

Relapsed/Refractory CLL Treatment Options

02:42

High response rates with T cell engagers in follicular lymphoma | Ryan Jacobs, MD | EHA 2024

05:04

CAR-T Therapy in patients 75+ with Relapsed/Refractory DLBCL | Pierre Bories, MD, PhD | EHA 2024

03:50

Outcomes in high-risk subgroups after ibrutinib and venetoclax for CLL | Ryan Jacobs, MD | EHA 2024

05:41

CAR T-cell Therapy After Failed Chemo & BTKi in Mantle Cell Lymphoma | Manali Kamdar, MD | EHA 2024

05:36

Epcoritamab's Impact on Treating Relapsed Follicular Lymphoma | Umberto Vitolo, MD | EHA 2024

02:51

Administering Outpatient CAR T-cell Therapy in Non-Hodgkin Lymphoma | Radhika Bansal, MD | EHA 2024

06:43

Liso-cel (Breyanzi) Shows Curative Potential in R/R DLBCL | Manali Kamdar, MD | EHA 2024

51:44

Fixed-Duration vs. Continuous-Duration CLL Medicines

01:07:26

Dietary Guidelines for Blood Cancer Patients After Treatment

56:27

CAR T-Cell Therapy Advances in Large B-Cell Lymphoma

53:38

What is Genetic Testing? What Does it Mean For MDS Patients? | Dr. Namrata Chandhok

51:06

All About Bispecific Antibodies for CLL with Dr. Adam Kittai

55:02

Treatment Assessments for AML Care | Dr. James Dugan

01:02:47

Treatment Decision Making For HR-MDS Patients | Dr. Justin Taylor